* EDELRIS *
2005 - Rhône-Alpes
Lyon
www.edelris.com Contract, Research
Key words: Screening, Medicinal chemistry, Small molecules, Mimetics, CombiChem
Mission: to design and produce innovative, therapeutically relevant, natural-mimetic screening compounds, in order to accelerate the hit-lead discovery process in pharmaceutical and biotech research organizations
Clients: Pharmaceutical industry
contact@edelris.com
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Spin-off |
Managing Dir.-CEO: Ortholand (Jean-Yves) [co-founder, born 1965, Ph.D., ex-Bayer, Rhône Poulenc Santé, Merck Santé]
Sc.Dir.-CSO: Greiner (Alfred) [co-founder, Ph.D., ex-Rhône Poulenc]
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): | Turnover (M€) : 0.285 (2005)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Multiple
Position : Subcontractor
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2008 .04 | Partnering research agreement with Roche to provide new compounds services for early stage | R&D | [3 years] |
| 2005 .02 | Company founded by Jean-Yves Ortholand, Alfred Greiner, Claude Lardy, Catherine Vidal, Didier Roche, from a R&D activity in Merck Lipha Santé | ORGF | [0 year] | Actualisation / Updating: 29-Jan-2009 |
|
